quinacrine has been researched along with thioguanine anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cavion, F; Decorti, G; Fazzi, EM; Ferraro, RM; Genova, E; Giliani, S; Lanzi, G; Lucafò, M; Masneri, S; Orcesi, S; Pelin, M; Stocco, G; Tommasini, A | 1 |
3 other study(ies) available for quinacrine and thioguanine anhydrous
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients.
Topics: Ataxia Telangiectasia; Autoimmune Diseases of the Nervous System; Biomarkers; Cell Line; Cell Proliferation; Cell Survival; Clinical Decision-Making; Dexamethasone; Dose-Response Relationship, Drug; Drug Resistance; Genetic Predisposition to Disease; Humans; Immunologic Factors; Induced Pluripotent Stem Cells; Lenalidomide; Mercaptopurine; Nervous System Malformations; Phenotype; Precision Medicine; Predictive Value of Tests; Quinacrine; Thalidomide; Thioguanine | 2020 |